192 related articles for article (PubMed ID: 9815767)
41. Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle.
Fujimoto J; Ichigo S; Sakaguchi H; Hirose R; Tamaya T
Mol Hum Reprod; 1998 May; 4(5):509-13. PubMed ID: 9665639
[TBL] [Abstract][Full Text] [Related]
42. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
[TBL] [Abstract][Full Text] [Related]
43. Expression of platelet-derived endothelial cell growth factor in non-small cell lung carcinomas: relationship to various biological factors.
Volm M; Mattern J; Koomagi R
Int J Oncol; 1998 Nov; 13(5):975-9. PubMed ID: 9772289
[TBL] [Abstract][Full Text] [Related]
44. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity.
Moghaddam A; Bicknell R
Biochemistry; 1992 Dec; 31(48):12141-6. PubMed ID: 1457409
[TBL] [Abstract][Full Text] [Related]
45. The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective.
Cole C; Foster AJ; Freeman S; Jaffar M; Murray PE; Strafford IJ
Anticancer Drug Des; 1999 Oct; 14(5):383-92. PubMed ID: 10766293
[TBL] [Abstract][Full Text] [Related]
46. [Expression and clinical significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor in renal cell carcinoma].
Huang X; Wang L; Shi HB; Zhang XJ; Men XW; Chen B; Wang XH
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3127-30. PubMed ID: 22340655
[TBL] [Abstract][Full Text] [Related]
47. Sulfasalazine down-regulates the expression of the angiogenic factors platelet-derived endothelial cell growth factor/thymidine phosphorylase and interleukin-8 in human monocytic-macrophage THP1 and U937 cells.
de Bruin M; Peters GJ; Oerlemans R; Assaraf YG; Masterson AJ; Adema AD; Dijkmans BA; Pinedo HM; Jansen G
Mol Pharmacol; 2004 Oct; 66(4):1054-60. PubMed ID: 15269287
[TBL] [Abstract][Full Text] [Related]
48. Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy.
Focher F; Spadari S
Curr Cancer Drug Targets; 2001 Aug; 1(2):141-53. PubMed ID: 12188887
[TBL] [Abstract][Full Text] [Related]
49. Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients.
Yamamoto Y; Toi M; Tominaga T
Oncol Rep; 1996 Sep; 3(5):863-5. PubMed ID: 21594469
[TBL] [Abstract][Full Text] [Related]
50. The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer.
Kikuno N; Yoshino T; Urakami S; Shigeno K; Kishi H; Hata K; Shiina H; Igawa M
Anticancer Res; 2003; 23(2B):1305-12. PubMed ID: 12820387
[TBL] [Abstract][Full Text] [Related]
51. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity.
Usuki K; Saras J; Waltenberger J; Miyazono K; Pierce G; Thomason A; Heldin CH
Biochem Biophys Res Commun; 1992 May; 184(3):1311-6. PubMed ID: 1590793
[TBL] [Abstract][Full Text] [Related]
52. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells.
Takahashi Y; Bucana CD; Liu W; Yoneda J; Kitadai Y; Cleary KR; Ellis LM
J Natl Cancer Inst; 1996 Aug; 88(16):1146-51. PubMed ID: 8757194
[TBL] [Abstract][Full Text] [Related]
53. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma.
Fujieda S; Sunaga H; Tsuzuki H; Tanaka N; Saito H
Clin Cancer Res; 1998 Jul; 4(7):1583-90. PubMed ID: 9676830
[TBL] [Abstract][Full Text] [Related]
54. Structural properties of 3.0 kb and 3.2 kb transcripts encoding platelet-derived endothelial cell growth factor/thymidine phosphorylase in A431 cells.
Usuki K; Gonez LJ; Wernstedt C; Morén A; Miyazono K; Claesson-Welsh L; Heldin CH
Biochim Biophys Acta; 1994 Jul; 1222(3):411-4. PubMed ID: 8038210
[TBL] [Abstract][Full Text] [Related]
55. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer.
Toi M; Inada K; Hoshina S; Suzuki H; Kondo S; Tominaga T
Clin Cancer Res; 1995 Sep; 1(9):961-4. PubMed ID: 9816067
[TBL] [Abstract][Full Text] [Related]
56. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer.
Toi M; Hoshina S; Taniguchi T; Yamamoto Y; Ishitsuka H; Tominaga T
Int J Cancer; 1995 Apr; 64(2):79-82. PubMed ID: 7542228
[TBL] [Abstract][Full Text] [Related]
57. Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.
Stevenson DP; Collins WP; Farzaneh F; Hata K; Miyazaki K
Am J Pathol; 1998 Nov; 153(5):1573-8. PubMed ID: 9811349
[TBL] [Abstract][Full Text] [Related]
58. Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.
Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Comley M; Whitehouse RM; Talbot DC; Gatter KC; Harris AL
Br J Cancer; 1997; 75(4):477-81. PubMed ID: 9052396
[TBL] [Abstract][Full Text] [Related]
59. Expression of platelet-derived endothelial cell growth factor and its potential role in up-regulation of angiogenesis in scarred kidneys secondary to urinary tract diseases.
Konda R; Sato H; Sakai K; Sato M; Orikasa S; Kimura N
Am J Pathol; 1999 Nov; 155(5):1587-97. PubMed ID: 10550316
[TBL] [Abstract][Full Text] [Related]
60. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.
Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
Br J Cancer; 1999 Mar; 79(7-8):1249-54. PubMed ID: 10098767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
